$19.35
Market Cap
$1.98B
Shares Outstanding
102.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 25, 2026
Round Lot
100
Locale
US
Day Open
$22.10
Day High
$23.21
Day Low
$19.00
Volume
4.21M
VWAP
$21.17
Prev Close
--
Transactions
--
Acc. Volume
--
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) closed the 2026-09-25 session at $19.35. The stock opened at $22.10 and traded between $19.00 and $23.21 during that session. Session trading volume was 4.2M shares. The volume-weighted average price (VWAP) is $21.17.
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
ADARx Pharmaceuticals, Inc. Common Stock has a market capitalization of $1.98 billion. ADRX is listed on the XNAS exchange. The recorded listing date is 2026-09-25.
On this page you can find market ADRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.